Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2023-09-01
Product name:
BRIMONIDINE
DIN:
02540673
Product Monograph/Veterinary Labelling:
Date:
2023-09-08
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MICRO LABS LIMITED
31 Race Course Rd
Bangalore
Karnataka
India
560001
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
52:40.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01EA05 BRIMONIDINE
Active ingredient group (AIG) number:See footnote5
0131859001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| BRIMONIDINE TARTRATE | 0.2 % / W/V |